SOTIO Biotech Sales Trigger
SOTIO Biotech names new CMO. Signal your inbox: pitch CTMS & regulatory intelligence to speed IND approvals, outmaneuver competitors, and drive your pipeline to close.
Published on
Do not index
Do not index
π Battle Card: SOTIO Biotech
Quick trigger:
Β
π€ Decision Maker in the News
- Vivi Boura, Chief Medical Officer Β· π LinkedIn
Β
π‘ Why It Matters
- This SOTIO Biotech sales trigger signals a ramp-up in clinical development and regulatory strategy at a critical inflection point for ADC and immunotherapy programs. β Source
Β
π― Core Pain Point
- Speed to IND/CTA approvals for next-gen ADCs
- Visibility into trial operations across global sites
Β
π° What to Pitch
- Primary: Clinical Trial Management System β Accelerate IND submissions & streamline patient enrollment
- Expansion: Regulatory Intelligence Platform β Proactive dossier prep & seamless cross-region compliance
Β
πΊοΈ Quick Context
- HQ: Prague, Czech Republic; Basel, Switzerland; Boston, MA
- Employees: β 200
- Rev: β $30 M
- Website: https://www.sotio.com/
Β
π€Ό Competitive Intel
Which other vendors youβll probably face to win SOTIO Biotechβs business.
Β
- Medidata β CTMS / EDC
- Unique edge: End-to-end trial optimization analytics
- Evaluated by CMO & VP Clinical for scalability
- Veeva Systems β Clinical Cloud Solutions
- Unique edge: Unified platform across clinical & regulatory
- Evaluated by IT & Ops for integration ease
- Oracle Health Sciences β CTMS / EDC
- Unique edge: Robust data management at scale
- Evaluated by CTO & Quality Management for data security
- PharmaLex β Regulatory Consulting
- Unique edge: Deep EU/US regulatory expertise
- Evaluated by Chief Medical Officer for submission support
- Parexel β Clinical Trial Services
- Unique edge: Global CRO network
- Evaluated by Procurement & PMO for operational support
Β
β Do-Now Checklist
Connect with Vivi Boura on LinkedIn (link above)
Reference the SOTIO Biotech sales trigger in your first outreach
Generate email + DM with the Copy-My-Prompt block and send first touch
Schedule follow-ups in CRM (Day 3 & Day 10)
Β
Next Step
Β
π§ Copy My Prompt for Personalized Cold Outreach
ββββββββββββββββββββββββββββ
βοΈ YOUR COMPANY
ββββββββββββββββββββββββββββ
OUR_COMPANY = β<your company>β
OFFER_BRIEF = βClinical Trial Management System to accelerate IND submissionsβ
PROOF_METRIC = β25% faster trial startupβ
CTA_STYLE = βquick_callβ
TONE = βfriendlyβ
ββββββββββββββββββββββββββββ
π TARGET COMPANY
ββββββββββββββββββββββββββββ
NAME = Vivi
COMPANY = SOTIO Biotech
DEPT = Clinical Development
SIZE = β15
BOTTLENECK = Speed to IND/CTA approvals
EVENT = Promotion of Vivi Boura to Chief Medical Officer
DETAIL = Promotion of Vivi Boura to Chief Medical Officer
PAIN = Visibility into trial operations across global sites
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20251103828716&div=41152219
SIM_CO = Seagen
WIN_METRIC = 25% faster trial startup
NEXT_SIZE = β30
EMP_EST = β200
REV_EST = β$30M
ββββββββββββββββββββββββ
TASK FOR CHATGPT
ββββββββββββββββββββββββ
Role: βNewsletterForLeads SDR-Assistβ.
Validate any β guesses via SRC.
EMAIL (keep breaks):
Subject: β15-person Clinical Development
Viviβnoticed your Clinical Development team is β15.
Thatβs when Speed to IND/CTA approvals slows growth.
We helped Seagen fix this with Clinical Trial Management System to accelerate IND submissions.
Result: 25% faster trial startup.
Quick call?
PSβnext bottleneck hits β30.
DM β€45 words, TONE:
Saw your post about Promotion of Vivi Boura to Chief Medical Officer β Visibility into trial operations across global sites.
Clinical Trial Management System to accelerate IND submissions. 25% faster trial startup. Quick chat?